Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4294620
Max Phase: Preclinical
Molecular Formula: C48H61N7O13S
Molecular Weight: 976.12
Molecule Type: Small molecule
Associated Items:
ID: ALA4294620
Max Phase: Preclinical
Molecular Formula: C48H61N7O13S
Molecular Weight: 976.12
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@@H]1CC[C@H]2[C@@H](C)C(OCCN3CCN(c4ccc(C(=O)NS(=O)(=O)c5ccc(NCC6CCOCC6)c([N+](=O)[O-])c5)c(Oc5cnc6[nH]ccc6c5)c4)C[C@@H]3CO)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4
Standard InChI: InChI=1S/C48H61N7O13S/c1-29-4-8-39-30(2)45(65-46-48(39)38(29)10-14-47(3,66-46)67-68-48)63-21-18-53-16-17-54(27-34(53)28-56)33-5-7-37(42(23-33)64-35-22-32-11-15-49-43(32)51-26-35)44(57)52-69(60,61)36-6-9-40(41(24-36)55(58)59)50-25-31-12-19-62-20-13-31/h5-7,9,11,15,22-24,26,29-31,34,38-39,45-46,50,56H,4,8,10,12-14,16-21,25,27-28H2,1-3H3,(H,49,51)(H,52,57)/t29-,30-,34-,38+,39+,45?,46-,47-,48-/m1/s1
Standard InChI Key: MUMUTRNJZDWKQM-AVRZGQHGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 976.12 | Molecular Weight (Monoisotopic): 975.4048 | AlogP: 5.93 | #Rotatable Bonds: 15 |
Polar Surface Area: 238.41 | Molecular Species: ACID | HBA: 17 | HBD: 4 |
#RO5 Violations: 3 | HBA (Lipinski): 20 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 4.18 | CX Basic pKa: 7.17 | CX LogP: 4.99 | CX LogD: 5.24 |
Aromatic Rings: 4 | Heavy Atoms: 69 | QED Weighted: 0.06 | Np Likeness Score: 0.18 |
1. Liu X, Zhang Y, Huang W, Luo J, Li Y, Tan W, Zhang A.. (2018) Development of high potent and selective Bcl-2 inhibitors bearing the structural elements of natural product artemisinin., 159 [PMID:30278333] [10.1016/j.ejmech.2018.09.059] |
Source(1):